Changing Compliance to the American College of Gastroenterology Guidelines for the Management of Variceal Hemorrhage: A Regional Survey

American Journal of Gastroenterology

Volumn 99, Issue 4, 2004, Pages 645-649

  Zaman, Atif ^a   Hapke, Ronald J ^a   Flora, Kenneth ^a   Rosen, Hugo R ^a   Benner, Kent G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; OCTREOTIDE;

ABDOMINAL BLEEDING; CLINICAL PRACTICE; DIAGNOSTIC VALUE; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES BLEEDING; HEALTH SURVEY; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; QUESTIONNAIRE; REVIEW; SCREENING; SELF REPORT; STOMACH VARICES BLEEDING; UNITED STATES;

ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; GUIDELINE ADHERENCE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; QUESTIONNAIRES;

EID: 2342605492     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.04145.x     Document Type: Review

References (19)

1. Garceau AJ, Chalmers TC. The Boston Inter-Hospital Liver Group. The natural history of cirrhosis. I. Survival with esophageal varices. N Engl J Med 1963;268:469-73.
2. Rigo GP, Merighi A, Chalen NJ, et al. A prospective study of the ability of three endoscopic classifications to predict hemorrhage from esophageal varices. Gastrointest Endosc 1992;38:425-29.
3. The Northern Italian Endoscopic Club for the Study and Treatment of Esophageal Varices: Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: A prospective multicenter trial. N Engl J Med 1988;319:983-89.
4. Gores GJ, Weisner RH, Dickson ER, et al. Prospective evaluation of esophageal varices in primary biliary cirrhosis: Development, natural history, and influence on survival. Gastroenterology 1989;96:1552-59.
5. Graham D, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-09.
6. Boyer T. Natural history of portal hypertension. Clin Liver Dis 1997;1:31-44.
7. Grace ND. Prophylaxis of first variceal bleeding. Drug treatment. In: Holstege A, Hahn EG, Scholmerich J, eds. Portal hypertension (Folk Symposium 79). Dordrecht, The Netherlands: Kluwer, 1995:269-77.
8. Teran JC, Imperiale TF, Mullen KD, et al. Primary prophylaxis of variceal bleeding in cirrhosis: A Cost Effectiveness Analysis. Gastroenterology 1997;112:473-82.
9. Cales P, Desmorat H, Vinel JP, et al. Incidence of large esophageal varices in patients with cirrhosis: Application to prophylaxis of first bleeding. Gut 1990;31:1298-302.
10. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: A meta-analytic review. Eur J Gastroenterol Hepatol 1995;22:332-54.
11. Grace N. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol 1997;92:1081-91.
12. Gralnek IM, Jensen DM, Jensen ME. Direct costs of hospital care in patients with active esophagogastric variceal hemorrhage treated with emergency endoscopic sclerotherapy or rubber band ligation in a prospective randomized trial. Gastroenterology 1996;110:A1200.
13. Poynard T, Cales P, Pasta L, et al. Beta-adrenergic antagonists in the prevention of first gastrointestinal bleeding in patients with cirrhosis and oesophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. N Engl J Med 191;324:1532-38.
14. Sarin S, Lamba GS, Kumar M, et al. Comparison of endoscopic ligation and propanolol for the primary prevention of variceal bleeding. N Engl J Med 1999;340:988-93.
15. Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Eur J Gastroenterol Hepatol 2001;33: 802-07.
16. Vinel JP, Lamouliate H, Cales P, et al. Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration. Gastroenterology 1992;102:1760-63.
17. Avgerinos A, Rekoumis G, Klonis C, et al. Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy: A randomized controlled trial. Eur J Gastroenterol Hepatol 1993;19:301-11.
18. Vicker C, Rhodes J, Chesner I, et al. Prevention of rebleeding from esophageal varices: Two year follow-up of a prospective controlled trial of propranolol in addition to sclerotherapy. Eur J Gastroenterol Hepatol 1994;21:87-91.
19. Acharya KS, Dasarthry S, Saksena S, et al. A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. Eur J Gastroenterol Hepatol 1993;19:291-300.